As a result, the regulatory environment for compounded GLP-1 medications continues to shift, and patient access pathways may change over time
On side effects, both classes most commonly produce gastrointestinal symptoms - nausea, vomiting, diarrhea, and constipation - primarily during dose escalation
International journal of molecular sciences, 24(15), 12152
Ive found out about lesser-known GLP-1 side effects directly from my patients, with a handful of them describing debilitating brain fog, another symptom that is underdiscussed but existent
La FDA ha aprobado la tirzepatida tanto para el tratamiento de la diabetes tipo 2 (bajo el nombre comercial Mounjaro) como para el control crnico del peso (como Zepbound)